{
    "2021-04-29": [
        [
            {
                "time": "2021-04-15",
                "original_text": "Eaton Vance Worldwide Health Sciences Fund's Top 4 1st-Quarter Trades",
                "features": {
                    "keywords": [
                        "Health",
                        "Sciences",
                        "Fund",
                        "Trades"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Covid Shots Come in Bulk. The World Needs Single Servings",
                "features": {
                    "keywords": [
                        "Covid",
                        "Shots",
                        "Bulk",
                        "World",
                        "Single Servings"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "cases",
                        "India",
                        "worse",
                        "improving"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Moderna ramps up investments to triple vaccine output, eyes boosters",
                "features": {
                    "keywords": [
                        "Moderna",
                        "investments",
                        "vaccine",
                        "output",
                        "boosters"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters",
                "features": {
                    "keywords": [
                        "Pfizer-BioNTech",
                        "Bullish",
                        "Vaccine",
                        "Trial",
                        "Infants",
                        "September"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "NYC reopening timeline is a ‘disastrous issue’: Doctor",
                "features": {
                    "keywords": [
                        "NYC",
                        "reopening",
                        "timeline",
                        "disastrous",
                        "issue"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Doctor: Travel ban from India to the U.S. could be 'counterproductive'",
                "features": {
                    "keywords": [
                        "Travel",
                        "ban",
                        "India",
                        "U.S.",
                        "counterproductive"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Bristol-Myers (BMY) Misses on Q1 Earnings, Opdivo Sales Decline",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Q1",
                        "Earnings",
                        "Opdivo",
                        "Sales",
                        "Decline"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Will Pfizer (PFE) Deliver a Beat This Earnings Season?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Earnings",
                        "Season",
                        "Beat"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Stock",
                        "Buy",
                        "Covid",
                        "Vaccine",
                        "Authorization"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "World to spend $157 billion on COVID-19 vaccines through 2025 -report",
                "features": {
                    "keywords": [
                        "World",
                        "spend",
                        "billion",
                        "COVID-19",
                        "vaccines",
                        "2025"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "UPDATE 1-BioNTech expects vaccine trial results for babies by September",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "vaccine",
                        "trial",
                        "babies",
                        "September"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "REFILE-BioNTech expects vaccine trial results for babies by September",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "vaccine",
                        "trial",
                        "babies",
                        "September"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}